Frank McCormick is Chairman at BridgeBio Pharma, Inc. (BBIO). They have made 5 open-market trades across 1 company since 2019, most recently 2026-06-22.
CIK 0001257809
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BBIO | SELL · 10b5-1 | 2025-10-29 | 2025-10-31 | $66.54 | $25.8M | +5.5% | +14.4% | +26.1% |
| BBIO | SELL · 10b5-1 | 2025-10-27 | 2025-10-29 | $65.00 | $107K | -4.9% | +9.0% | +17.9% |
| BBIO | SELL | 2025-09-05 | 2025-09-08 | $53.16 | $7.9M | -1.4% | +2.2% | +37.3% |
| BBIO | SELL · 10b5-1 | 2025-06-24 | 2025-06-26 | $44.23 | $4.4M | +1.8% | +2.3% | +12.1% |
| BBIO | SELL · 10b5-1 | 2023-12-26 | 2023-12-28 | $42.06 | $4.2M | -4.4% | -9.4% | -26.1% |
| BBIO | SELL | 2020-11-13 | 2020-11-17 | $42.76 | $8.6M | +15.9% | +48.6% | +49.9% |
| BBIO | SELL | 2019-12-30 | 2019-12-31 | $35.74 | $581K | -4.4% | -0.7% | -24.2% |
| BBIO | SELL | 2019-12-27 | 2019-12-31 | $37.84 | $3.1M | -4.4% | -0.7% | -24.2% |
| BBIO | SELL | 2019-12-27 | 2019-12-31 | $37.80 | $4.4M | -4.4% | -0.7% | -24.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.